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Abstract
Neuromuscular junction (NMJ) research is vital to advance the understanding of neu-
romuscular patho- physiology and development of novel therapies for diseases as-
sociated with NM dysfunction. In vivo, the micro- environment surrounding the NMJ 
has a significant impact on NMJ formation and maintenance via neurotrophic and 
differentiation factors that are secreted as a result of cross- talk between muscle fibers 
and motor neurons. Recently we showed the formation of functional NMJs in vitro in 
a co- culture of immortalized human myoblasts and motor neurons from rat- embryo 
spinal- cord explants, using a culture medium free from serum and neurotrophic or 
growth factors. The aim of this study was to assess how functional NMJs were estab-
lished in this co- culture devoid of exogenous neural growth factors. To investigate 
this, an ELISA- based microarray was used to compare the composition of soluble en-
dogenously secreted growth factors in this co- culture with an a- neural muscle culture. 
The levels of seven neurotrophic factors brain- derived neurotrophic factor (BDNF), 
glial- cell- line- derived neurotrophic factor (GDNF), insulin- like growth factor- 
binding protein- 3 (IGFBP- 3), insulin- like growth factor- 1 (IGF- 1), neurotrophin- 3 
(NT- 3), neurotrophin- 4 (NT- 4), and vascular endothelial growth factor (VEGF) were 
higher (p < 0.05) in the supernatant of NMJ culture compared to those in the superna-
tant of the a- neural muscle culture. This indicates that the cross- talk between muscle 
and motor neurons promotes the secretion of soluble growth factors contributing to 
the local microenvironment thereby providing a favourable regenerative niche for 
NMJs formation and maturation.
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1 |  INTRODUCTION
Neuromuscular Junctions (NMJs) are the highly specialized 
peripheral synapses that translate neural signals received 
from motor neurons to contractile activity in skeletal muscle 
cells (Witzemann, 2006). During embryological myogenesis 
cross- talk between muscle fibers and motor neurons appears 
indispensable for the development and maintenance of the 
neuromuscular system (Cisterna et al., 2014). The significance 
of this cross- talk is also reflected by the limited differentiation 
in vitro of a- neurally cultured skeletal muscle cells to non- 
contracting myotubes (Delaporte et al., 1986) that contrasts 
with highly differentiated contracting myotubes in co- cultured 
skeletal muscle cells and motor neurons (Saini et al., 2019). 
The interdependence of these tissues is further apparent when 
considering neurodegenerative disorders where damage or pa-
thologies of peripheral nerves is associated with significant 
muscle wasting and degeneration (Tintignac et al., 2015). 
These observations indicate that particularly muscle cell dif-
ferentiation is dependent not only on functional innervation, 
but also on the cross- talk between muscle cells and the ner-
vous system. This could be orchestrated via the secretion of 
critical trophic factors released into their microenvironment.
Skeletal muscle cells are an important source of growth 
factors, cytokines and neurotrophins. They also express many 
receptors for these growth factors, suggesting that neurotrophic 
signalling plays an important role in skeletal muscle cell devel-
opment and innervation (Chevrel et al., 2006; Gonzalez et al., 
1999; Griesbeck et al., 1995; Sakuma & Yamaguchi, 2011). 
Indeed, neurotrophin- 4 (NT- 4) and neurotrophin- 5 (NT- 5) null 
mice display clear defects in muscle development and func-
tion, indicating the significance of NT- 4/5 in skeletal muscle 
fiber differentiation (Carrasco & English, 2003). Additionally, 
neurotrophin- 3 (NT- 3) has been implicated in the formation 
of muscle spindles (Ernfors et al., 1994) and some dystrophic 
muscle pathologies have been linked with altered nerve growth 
factor (Capsoni et al., 2000). The discovery of BDNF receptor 
expression in skeletal muscle cells and muscle satellite cells 
has opened up interest to its postulated role in skeletal mus-
cle cell development and regeneration (Chevrel et al., 2006). A 
study investigating the role of BDNF identified its supportive 
function in MN growth, survival, differentiation, regeneration 
and synaptic differentiation (Lee & Jun, 2019) while another 
study demonstrated the importance of BDNF.
For normal myogenic differentiation and regeneration fol-
lowing injury (Kolarow et al., 2007). Interestingly, in skeletal 
muscle cells BDNF knockout was associated with increased 
myoblast differentiation and the maintenance of the satellite 
cell population (Mousavi & Jasmin, 2006). This may explain 
why an increase in BDNF expression has been observed fol-
lowing various peripheral nerve injuries denoting its role in 
stimulating satellite cells in muscle damage (Omura et al., 
2005). Likewise findings from BDNF null and muscle specific 
BDNF KO mice studies exhibited inhibition of myogenic dif-
ferentiation and regeneration (Clow & Jasmin, 2010). BDNF 
signalling has also been shown to promote the withdrawal of 
weaker motor neuron contacts whilst leaving active motor 
neuron terminals intact, thereby regulating synaptic density 
in synaptogenesis (Garcia et al., 2010). Furthermore, the 
smaller muscles from diabetic than normal mice show a lower 
expression of NT- 3 and NGF mRNA and a higher expres-
sion of BDNF mRNA (Fernyhough et al., 1995, 1996, 1998; 
Fernyhough, Diemel, Hardy, et al., 1995; Ihara et al., 1996).
The glial- cell- line- derived neurotrophic factor (GDNF), 
first discovered in glial cells, plays a role in the support of 
central nervous system dopaminergic neurons (Lin et al., 
1993). It has been shown that overexpression of GDNF in 
skeletal muscle cell induces hyper innervation through in-
creased sprouting (Nguyen et al., 1998), which corresponds 
with the significant transient expression of GDNF at NMJs 
during embryonic myogenesis in vivo. Given these observa-
tions, it has been suggested that GDNF may help maintain 
cholinergic motor neurons throughout aging (Ulfhake et al., 
2000) and the increased GDNF expression in denervated 
human skeletal muscle cells (Lie & Weis, 1998) may be part 
of an attempt to restore innervation.
Vascular endothelial growth factor (VEGF) is not only an 
endothelial mitogenic factor, but also plays an important role 
in maintenance of the motor neuron. Therefore, it is considered 
a promising therapeutic agent for amyotrophic lateral sclerosis 
and other neurodegenerative diseases (Tovar et al., 2014).
As discussed above, endogenous growth factors and 
neurotrophins are vital for survival, development, plasticity 
and function of neurons, muscle and NMJ in vivo (Huang 
& Reichardt, 2001). Therefore, it is not surprising that most 
muscle- nerve co- cultures introduce exogenous growth fac-
tors (Das et al., 2007; Guo et al., 2011, 2014; Puttonen et al., 
2015; Rumsey et al., 2010). While this enhances differentia-
tion, it at the same time complicates drug discovery and toxi-
cology studies due to possible interactions of the compounds 
being screened with factors contained within the culture 
media (Dugger et al., 2018; Holohan et al., 2013). This com-
plication may be one of the explanations for the poor transla-
tion of many promising therapies to clinical application.
To overcome this problem, we recently developed a nerve- 
muscle co- culture system that resulted in the development of 
functional NMJ and highly differentiated contracting myotubes, 
without the need of serum or growth factors in the medium (Saini 
et al., 2019, 2020; Abd Al Samid et al., 2018). This suggests 
that all the factors required for the formation and maturation of 
NMJ and advanced differentiation of skeletal muscle cells were 
secreted endogenously. We, therefore, hypothesized that motor 
neurons and skeletal muscle cells in this co- culture platform 
release all the necessary factors to stimulate myotube differ-
entiation, sprouting of MN axons, and formation of functional 
NMJs. To investigate this, we applied immunohistochemistry to 
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confirm the formation of NMJs, and ELISA- based microarrays 
on supernatants collected form a- neurally cultured human myo-
blasts and myoblasts co- cultured with rat- embryo spinal- cord 
explants to examine the concentration of endogenously secreted 
growth factors and neurotrophins.
2 |  MATERIAL AND METHODS
2.1 | Human myoblasts cell culture
Immortalized human myoblasts were cultured as described 
previously (Saini et al., 2019). Briefly, cells were seeded 
on 6- well plates coated with 0.2% gelatin at a density of 
150 × 103 cells/mL. After 24 h, when the myoblast density 
reached ~90% confluency, they were washed twice with 
DPBS and incubated for 24 h at 37°C with 5% CO2 in dif-
ferentiation medium (DM), consisting of 99% (v/v) DMEM, 
1% (v/v) L- glutamine, 10 µg/mL recombinant human insu-
lin, and 10 µg/mL gentamicin, before plating the rat- embryo 
spinal- cord explants.
2.2 | Isolation of rat embryonic spinal 
cord explants
All animal work undertaken was approved by the Home 
Office. Isolation of rat- embryo spinal- cord explants was 
carried out as described previously (Saini et al., 2019). The 
uterine horn was removed from the pregnant rat and embryo 
dissection was performed in a 100- mm dish under a binocular 
microscope using 21- gauge needles. The rat- embryo spinal- 
cord explant was dissected in one piece from each embryo 
and the surrounding connective tissue was removed, ensuring 
the dorsal root ganglia remained intact and attached to the 
rat- embryo spinal- cord explant, which was cut transversally 
into ~1– 2 mm3 explants.
2.3 | Co- culture NMJ model and 
Immunocytochemistry
The co- culture NMJ model was established and character-
ized by immunohistochemistry as described previously 
(Saini et al., 2019, 2020). Briefly, the DM was removed 
from the 6- well plates and the cells were washed twice with 
DPBS. Then, 700 µL DM was added to each well. Three to 
six evenly spaced explants were placed into each well and 
incubated for 6  h to allow the explants to adhere with the 
SkMCs. Following the 6- h incubation, additional DM was 
added dropwise to each dish to prevent dehydration of the 
skeletal muscle cells and rat- embryo spinal- cord explants. 
The cells were then incubated for an additional 24 h before 
adding further DM to each well. Between 24 and 48 h, the 
myocytes fuse into immature myotubes and sprouting neu-
rites from the explants innervate the cells. Co- cultures were 
maintained by changing half the DM every 48 h. Live cells 
were visualized using a Leica DMI6000 B inverted micro-
scope from Leica Microsystems. Functional NMJ model was 
characterized using the primary antibodies (Anti- Choline 
Acetyltransferase (ChAT) from Merck Millipore 1:100; α- 
Bungarotoxin, Alexa Fluor® 647 conjugate 1:400; Myosin 4 
monoclonal antibody (MF20), Alexa Fluor® 488- anti- MHC 
1:500) that were added to the cells and incubated for 18– 24 h 
at 4°C. Confirmation of myotube innervation and NMJ for-
mation was assessed via confocal and immunofluorescence 
microscopy using a Leica DMI6000 B inverted microscope 
and a Leica TCS SP5 confocal microscope.
2.4 | ELISA- based microarray
In parallel, experiments were conducted to compare the con-
centration of 40 human growth factors in aneural myotube 
cultures and co- cultured myotubes. One ELISA- based micro-
array standard glass slide is spotted with 16 wells of iden-
tical growth factor antibody arrays (Human Growth Factor 
Antibody, Cambridge Bioscience). Each well was spotted 
with different controls: positive control spot (a control for 
the amount of biotinylated antibody printed onto the array), 
negative control spot (buffer printed, to measure the baseline 
responses) and a blank spot (nothing printed, to measure the 
background response). Each antibody was arrayed in quadru-
plicate. On day 7, when spontaneous myotube contractions in 
unison as a motor unit were first observed, supernatants were 
collected from both conditions using a human growth factor 
array kit, as described by the manufacturer. The total protein 
concentration of each sample was determined with a protein 
assay kit (Pierce™ BCA Protein Assay Kit, Thermo Fisher) 
to ensure loading equal amounts of protein. The array spot 
signal densities were quantified with a GenePix 4000B laser 
scanner at 532 nm wavelength. Raw data from the visualized 
array images was generated and processed with the GenePix 
Pro 4.1 Microarray Acquisition & Analysis Software, fur-
ther statistical analysis of the data was performed with the 
RayBiotech Q- Analyzer® tool Software for QAH- GF- 1.
2.5 | Statistical analyses
The results presented are representative of a minimum of 
three independent experiments. Results were analyzed using 
SPSS 25.0 statistical analysis software with an independ-
ent 2- sided t- test. Normality of the data was tested with the 
Shapiro– Wilk test, and if data were not normally distrib-
uted they were log- transformed before applying the t- test. 
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Data were expressed as mean plus/minus standard deviation 
(±SD). Statistical differences were analysed with unpaired t 
test. Statistical significance was accepted if p < 0.05.
3 |  RESULTS
3.1 | Co- culture and NMJ formation
To study the cross- talk between muscle and motor neurons, 
we used our previously established co- culture NMJ model 
(Saini et al., 2019). At day 7 of this co- culture platform, the 
rat- embryo spinal- cord explants sprouted cholinergic motor 
neurons that branched to form multiple neuromuscular in-
nervation site (Figure 1a). At the same time, the immortal-
ized human myoblasts differentiated into striated myotubes 
with peripherally located nuclei and expressed acetylcholine 
receptors, as reflected by the α- BTX stain as red clusters, 
confirming NMJ formation (Figure 1a). Aneurally cultured 
myoblast, on the other hand, did not show such a high de-
gree of differentiation, as reflected by the absence of cross- 
striation and peripherally located nuclei (Figure 1b).
We also cultured just rat- embryo spinal- cord explants, to 
collect supernatant but they typically deteriorated and de-
tached form the surface of the culture plate, despite it exhib-
ited some growth with thin short neural outgrowth (Figure 2, 
left panel) within 72 h. At 7 day, rat- embryo spinal- cord ex-
plants were completely deformed and nothing was observed 
under the microscope. In contrast, rat- embryo spinal- cord 
explants co- culture was intact at 72 h (Figure 2 right panel) 
sprouted long large axons compared with rat- embryo spinal- 
cord explants mono- culture.
3.2 | Quantification of growth and 
neurotrophic factors
To examine whether the co- culture of myoblasts with rat- 
embryo spinal- cord explants enhances the endogenous 
secretion of the essential neural growth factor required for 
the formation of functional NMJs, an ELISA- based microar-
ray was performed on supernatant collected from the two cul-
ture conditions (co- culture and a- neural muscle). Among 40 
growth/neurotrophic factors were quantified on day 7, seven 
factors were significantly more abundant in the co- culture 
than in the a- neurally cultured myotubes (p < 0.05).
The concentrations of brain- derived neurotrophic 
factor (BDNF, p  <  0.001, Figure 3a), glial cell- derived 
neurotrophic factor (GDNF, p = 0.01, Figure 3b), insulin- 
like growth factor- binding protein (IGFBP- 3, p < 0.001, 
Figure 3c) insulin- like growth factor 1 (IGF- 1, p = 0.043, 
Figure 3d), neurotrophin (NT- 3, p < 0.001, Figure 3f) neu-
rotrophin −4 (NT- 4, p  =  0.006, Figure 3g), and vascu-
lar endothelial growth factor (VEGF, p  <  0.001, Figure 
3h) were higher in the supernatant collected from the co- 
cultures compared to the supernatant from a- neurally cul-
tured myotubes, respectively.
4 |  DISCUSSION
Our co- culture of human myoblasts and rat- embryo spinal- 
cord explants displays a high degree of myotube differen-
tiation. Perhaps even more important is that the contraction 
of the myotubes in unison is realized through activation 
via functional NMJs as indicated by cessation of contrac-
tions by, for example, α- bungarotoxin (Saini et al., 2020). 
As this functional innervation occurred without the addition 
of serum or growth factors to the system, it gave us the op-
portunity to assess the secretome of the system to obtain an 
indication of growth factors that most likely are essential for 
the formation of functional NMJs and muscle differentiation. 
Here we found that the abundance of BDNF, GDNF, NT- 
3, NT- 4, VEGF, IGF- 1, and IGFBP- 3 were all higher in the 
co- culture system than in a- neurally cultured myoblasts. This 
suggests that the cross- talk between the neural and muscle 
tissue enhances the secretion of growth factors important for 
muscle differentiation and NMJ formation and maintenance. 
F I G U R E  1  Image of neuromuscular junctions (NMJ) in the co- culture of immortalized human skeletal muscle cells with rat- embryo spinal- 
cord explants (a) and aneurally cultured immortalized human skeletal muscle cells (b) at day 7. The panel A shows a representative image of a co- 
culture stained for choline acetyltransferase (ChAT, green), α- BTX (red), myosin heavy chain (MHC, magenta), and DAPI (blue). (a) white arrows 
indicate the terminal of motor neurons end at α- BTX confirming the formation of NMJ. Yellow arrow indicates peripherally located nucleus. Scale 
bar = 25 µm.
(a) (b)
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The observation that a mono- culture of rat- embryo spinal- 
cord explants did not grow for 7 days and usually deterio-
rate within 72  h further indicates that the cross- talk is not 
only important for the maintenance and differentiation of the 
muscle cells, but also for the maintenance of the rat- embryo 
spinal- cord explants.
It has been reported that BDNF not only enhances the 
transmission at the NMJ, but also skeletal muscle innervation 
and motor neuron survival (Yan et al., 1993; Zhang & Poo, 
2002). This corresponds with the observation that myoblasts 
transiently express high levels of BDNF during embryonic 
development in vivo during NMJ and skeletal muscle fiber 
maturation (Griesbeck et al., 1995). Perhaps somewhat para-
doxically, chronic exposure to elevated BDNF levels inhibited 
synaptogenesis in vitro (Peng et al., 2003) and in combination 
these data suggest that the timing of elevated BDNF levels is 
important not only for the NMJ formation during early muscle 
development, but also to allow pruning of the multiple NMJs 
on a single fiber during early muscle development. In line 
with this, we found here a 10- fold higher BDNF concentration 
in the co- culture system with functional NMJs than in the a- 
neurally cultured system without NMJs. These results provide 
evidence that the endogenously secreted BDNF in the present 
co- culture system allowed for the physiological formation and 
development of NMJs, similar to in vivo NMJ formation.
Other nerve- muscle co- culture systems require the inclu-
sion of exogenous BDNF (Das et al., ,,2007, 2010; Guo et al., 
,2011, 2014, 2017; Puttonen et al., 2015; Rumsey et al., 2010; 
Smith et al., 2016; Vilmont et al., 2016) and yet do not gen-
erate the functional NMJ observed in our co- culture system. 
This may well be a reflection of unsuitable concentrations of 
exogenous BDNF inhibiting NMJ maturation (Song & Jin, 
2015) and/or illustrate the importance of the temporal vari-
ations in BDNF concentrations for NMJ formation as seen 
during in vivo NMJ formation. It is thus of interest to investi-
gate the time course of the changes in BDNF concentrations 
in our co- culture system during the development of NMJs 
and to what extent these changes in BDNF concentration are 
associated with multiple innervation.
We also observed elevated GDNF in the co- cultures in 
comparison to myotube monocultures. GDNF is a key factor 
for motor neuron survival in vitro (Oppenheim et al., 1995). 
Intriguingly, GDNF is expressed by skeletal muscle while its 
receptor RET tyrosine kinase is expressed in the motor neu-
rons (Baudet et al., 2008), a design illustrating the cross- talk 
between the skeletal muscle and motor neurons. The signif-
icance of this receptor became apparent as obvious disrup-
tions to motor neuron maturation and reduced MEP size at 
NMJs when conditionally ablating RET tyrosine kinase in 
the cranial motor neurons of mice (Baudet et al., 2008). In ad-
dition, a frog nerve- muscle co- culture system demonstrated 
that treatment with GDNF led to an increase in spontaneous 
synaptic current frequency and amplitude, further indicating 
its possible role as a retrograde signalling factor (Wang et al., 
2002). Furthermore, studies with transgenic mice that over-
express skeletal muscle- derived GDNF showed hyperinner-
vation of NMJs (Nguyen et al., 1998), motor unit enlargement 
and slowed synapse elimination (Keller- Peck et al., 2001). 
These findings suggest skeletal muscle- derived GDNF plays 
a role in the regulation of maturation of the NMJ and that the 
elevated GDNF in our co- culture system enhances the dif-
ferentiation of pre- and post- synaptic components of NMJs 
in the system. Given the hyperinnervation with continuous 
GDNF stimulation (21, 45), it would be of interest to assess 
the time course of the GDNF levels, and how it is related to 
the maturational status and potential multiple innervation in 
our system.
IGF- 1 is a potent anabolic hormone that has been shown 
to induce hypertrophy in skeletal muscle in animal models 
and muscle cell culture systems (Velloso, 2008). The mus-
cle specific IGF- 1 also plays a role in stabilizing NMJs and 
enhanced motor neuronal survival (Dobrowolny et al., 2005) 
and when injected directly into skeletal muscle of mice, 
IGF- 1 inhibits degeneration of motor neurons and NMJs, 
and the associated age- related decline in force generating 
capacity (Payne et al., 2006). The IGF- 1 bioavailability is 
enhanced through the activity of the IGFBPs (Stewart et al., 
1993). IGFBP- 3 is the most common protein of the IGFBP 
F I G U R E  2  A representative image of mono- and co- culture of RESCE at 72 h. Left panel: shows the deterioration of the mono- culture of 
rat- embryo spinal- cord explants with small and short axons indicated by the black arrows. Right panel: demonstrates intact co- culture of rat- embryo 
spinal- cord explants with large long axons indicated by white arrows. Scale bar =50 µm.
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superfamily (Adachi et al., 2017), acts as a membrane trans-
porter protein for IGF- 1 (Hwa et al., 1999) and binds 80% of 
the circulating IGF- 1 with a 1:1 ratio. Noteworthy, IGFBP- 3 
was also the most abundant IGFBP in both the co- cultures 
and monocultures. In addition to IGF- 1, also IGFBP- 3 ex-
pression was elevated in the co- cultures and further indicates 
the significance of the cross- talk between rat- embryo spinal- 
cord explants and skeletal muscle cells in advanced differ-
entiation of myofibers, and the formation of robust NMJ, 
comparable to the development in vivo.
NT- 3 and NT- 4 were also elevated in the co- cultures 
when compared to a- neural myotube cultures. Studies have 
demonstrated that NT- 3 and NT- 4 are important modulators 
of synaptic function and development, and are required for 
maintenance of presynaptic and postsynaptic structures at 
the NMJ (Belluardo et al., 2001; Gonzalez et al., 1999). In 
addition, NT- 3 plays an important role in motor neuron dif-
ferentiation as reflected by the smaller motor neuron soma 
size during early postnatal development of NT- 3- deficient 
mice, even though the number of α- motor neurons was not 
significantly affected (Woolley et al., 1999). This smaller 
motor neuron size in NT- 3- deficient mice was accompanied 
by a decreased number of motor end plates (MEPs) and a 
lower number of skeletal muscle fibers at birth, followed by 
a catastrophic postnatal loss of motor neurons and complete 
denervation of hindlimb muscles with no observable NMJ 
F I G U R E  3  Scatter graphs for trophic factor quantified by ELISA- based microarray of (a) BNDF, (b) GDNF, (c) IGFBP- 3, (d) IGF- 1, (e) NT- 
3, (f) NT- 4, (g) VEGF. Data are presented as mean ± standard deviation. Each data point is the average of three independent experiments, p < 0.05 
were considered statistically significant.
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remaining (Woolley et al., 2005). Similar observations were 
made in mice with haploinsufficiency- induced reductions 
in NT- 3 (Sheard et al., 2010) and indicate the importance 
of NT- 3 in NMJ formation, and muscle development and 
maintenance. Another neurotrophin, NT- 4, has been shown 
to enhance NMJ transmission in a phrenic nerve / adult rat 
diaphragm- muscle system during transmission failure in-
duced by repetitive nerve stimulation (Mantilla et al., 2004). 
Interestingly, the expression of NT- 4 is dependent on syn-
apse activity at the NMJ, as blockade of AChRs on the NMJ 
MEP with α- BTX caused a reduced NT- 4 expression, while 
electrical stimulation of motor neurons enhances skeletal 
muscle- derived NT- 4 expression (Funakoshi et al., 1995). 
The elevated expression of NT- 3 and NT- 4 in our co- culture 
system may thus well have contributed to NMJ formation, 
development and synaptic activity.
The concentration of VEGF, a member of the VEGF 
sub- family, was also significantly elevated in the co- 
cultures when compared to the a- neural myotube cultures. 
Originally described for their angiogenic role (Ferrara, 
2004), the VEGF family of factors has also important 
functions in motor neuron growth, guidance, migration, 
and survival (Rosenstein et al., 2010; Ruiz de Almodovar 
et al., 2009). Indeed, in amyotrophic lateral sclerosis trans-
genic mice systemic administration of VEGF resulted in 
an increase in the number of NMJs in the diseased mice 
(Zheng et al., 2007). Furthermore, administration of VEGF 
in mice with ischemic injury promoted both regrowth and 
maintenance of damaged motor neuron axons in the mice 
(Shvartsman et al., 2014) and was accompanied with an 
increased expression of GDNF and NGF that aid motor 
neuron axon regeneration (Shvartsman et al., 2014). Thus, 
the higher VEGF expression in the co- culture than the 
a- neurally cultured myoblasts may well have led to the 
elevated expression of GDNF in the co- culture and the de-
velopment of functional NMJs.
5 |  LIMITATION
It should be noted that our array was human- specific and we 
had a rat- human co- culture. This may be considered a limita-
tion, but growth factors are quite similar in rats and humans. 
Perhaps even more indicative that this is a minor problem 
was our ability to detect significant differences in the ex-
pression of growth factors between the aneurally cultured 
human myoblasts, and the rat- embryo spinal- cord explants 
and human myoblast co- culture. It remains to be seen, how-
ever, whether the growth factors have a neural or muscular 
origin in this co- culture system. Even if cross- reactivity is a 
problem, our co- culture system clearly showed the beneficial 
effects of cross- talk between muscle and MN on NMJ for-
mation that was related to elevated concentrations of growth 
factors in the medium that must have come from the nervous 
and/or muscle cells in the system.
6 |  CONCLUSION
In summary, this study shows that the formation of functional 
NMJs is the result of an orchestrated cross- talk between 
motor neurons and muscle fibers through endogenously re-
leased trophic and growth factors. Furthermore, the results 
demonstrated the formation and development of NMJs as 
well as advanced differentiation of immortalized human my-
otubes in vitro, through the precise expression of essential 
growth factors and neurotrophins. It can not be excluded that 
other secreted proteins contribute to this bidirectional com-
munication. Future studies using high- throughput microar-
rays, such as antibody- microarrays, may identify additional 
differentially expressed proteins in the secretome. Thus, this 
novel co- culture system, free from serum, growth, and neu-
rotrophic factors is an ideal in vitro NMJ model to screen po-
tential drugs and molecules of interest to treat neuromuscular 
and neurodegenerative disorders.
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